EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis

Yuemei Zhang iD, Yuxin Cao iD, Yongxin Sun, Chenxia Zhou iD, Xiaorui Lyu iD, Daixi Wang, Jiangfei Zheng iD, Yuxin Shu iD, Lijun Yao iD, Rong Zhang iD, Jingyong Li iD, Feng Jiang iD und 3 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2517531122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Yuemei Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai…. Hauptthemen laut MEDLINE: Atherosclerosis, Monocytes, Macrophage Activation, Macrophages. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | NSFC | National Science Fund for Distinguished Young Scholars (National Science Foundation for Distinguished Young Scholars), MOST | National Natural Science Foundation of China (NSFC), Shanghai Rising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The activation of blood monocytes and the infiltration of monocyte-derived macrophages into the vessel walls are the central part of atherosclerosis. However, the mechanisms underlying the processes remain unclear. Here, we report that G-protein signaling modulator 1 (GPSM1) plays a critical role in atherogenesis. We found that GPSM1 expression in lesional macrophages was increased during atherosclerosis development both in mice and humans. Myeloid-specific GPSM1 ablation protects mice against atherosclerosis and reduces aortic inflammation in both Apoe −/− mice and an AAV-PCSK9 injection model. Conversely, myeloid-restricted overexpression of GPSM1 accelerates aortic inflammation and promotes atherosclerosis development in mice. Mechanistically, GPSM1 deficiency suppressed monocyte activation including chemotaxis and adhesion through inhibition of the p38/ERK MAPK pathway regulated by the cAMP/PKA/KLF4/PMP22 axis, thereby alleviating proinflammatory responses within atherosclerotic plaques. Blockade of PMP22 using siRNA-loaded liposomes protected GPSM1 overexpression mice from atherosclerosis. Furthermore, a small-molecule compound inhibiting GPSM1 function could suppress atherosclerosis in vivo. In conclusion, our findings establish that GPSM1 is a regulator of atherosclerosis development and targeting GPSM1 might be a promising therapy against atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisMonocytesMacrophage ActivationMacrophagesChemotaxisAnimalsMiceHumansKruppel-Like Factor 4Disease ProgressionMice, Inbred C57BLMaleMice, Knockout, ApoE

Stichwörter der Autor:innen

GPSM1atherosclerosischemotaxismacrophagesmonocytes

Substanzen

Klf4 protein, mouseKruppel-Like Factor 4KLF4 protein, human

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Sha…
  • Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

ORCID-Profile: Yuemei Zhang, Yuxin Cao, Chenxia Zhou, Xiaorui Lyu, Jiangfei Zheng, Yuxin Shu, Lijun Yao, Rong Zhang, Jingyong Li, Feng Jiang, Jing Yan, Cheng Hu

Förderung

  • MOST | NSFC | National Science Fund for Distinguished Young Scholars (National Science Foundation for Distinguished Young Scholars)
  • MOST | National Natural Science Foundation of China (NSFC)
  • Shanghai Rising-Star Program

Zitieren

APA

Zhang, Y., Cao, Y., Sun, Y., Zhou, C., Lyu, X., Wang, D., Zheng, J., Shu, Y., Yao, L., Zhang, R., Li, J., Jiang, F., Cheng, X., Yan, J., & Hu, C. (2025). Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2517531122

Vancouver

Zhang Y, Cao Y, Sun Y, Zhou C, Lyu X, Wang D, et al. Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2517531122

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuemei and Cao, Yuxin and Sun, Yongxin and Zhou, Chenxia and Lyu, Xiaorui and Wang, Daixi and Zheng, Jiangfei and Shu, Yuxin and Yao, Lijun and Zhang, Rong and Li, Jingyong and Jiang, Feng and Cheng, Xiang and Yan, Jing and Hu, Cheng},
  title = {Myeloid GPSM1 regulates atherosclerosis progression by governing monocyte and macrophage activation and chemotaxis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2517531122}
}
Kostenlos starten →